Distribution of Clostridium Difficile Ribotypes in Macedonian Patients and their Antimicrobial Susceptibility

Kiril Mihajlov; Aneta Andreska; Nadica Ristovska; Tatjana Grdanoska; Elena Trajkovska Dokich

doi:https://oamjms.eu/index.php/mjms/article/view/oamjms.2019.482/3518

Distribution of Clostridium Difficile Ribotypes in Macedonian Patients and their Antimicrobial Susceptibility

Journal

Open Access Macedonian Journal of Medical Sciences

Date Issued

2019

Author(s)

Aneta Andreska

Nadica Ristovska

DOI

https://oamjms.eu/index.php/mjms/article/view/oamjms.2019.482/3518

Abstract

BACKGROUND:Clostridium difficileis a major nosocomial pathogen. In Europe, this bacterium is mostly characterised by PCR ribotyping. Most of the Clostridium difficileinfections (CDI) are treated with vancomycin or metronidazole, although prolonged antibiotic use is considered as one ofthe main risk factors for CDI.AIM: This study aimedto detect the presence of various C. difficileribotypes in hospitalised patients and to investigate their toxigenicity and antibiotic susceptibility.MATERIAL AND METHODS:All stool samples obtained from each patient were inoculated on Columbia blood agar and cycloserine cefoxitine fructose agar (CCFA) for isolation of C. difficile. Glutamate dehydrogenase and toxins A and B were investigated by immunochromatographic tests. Final confirmation of the isolates was performed by Vitek 2 and MALDI-TOF. A total of 21 isolates were collected for further investigation. PCR ribotyping was performed as described by Janezic and Rupnik. PCR ribotype profiles were analysed using software (Bionumerics, Applied Maths).Antibiotic susceptibility was determined by E-tests for metronidazole, vancomycin, tetracycline, clindamycin, erythromycin, imipenem, ciprofloxacin and moxifloxacin.RESULTS:About 48% of C. difficileisolates belonged to ribotype 001/072. So, this ribotype was the most common ribotype in this study. The remaining 52% of C. difficileisolates consisted of 10 different ribotypes: 017, SLO 160, SLO 187, SLO 120, 255/258, 014/020, 046, 002, 070 and 027. Furthermore, 20 (95.2 %) out of 21 isolates of C. difficilewere toxigenic. Toxins A and B were detected simultaneously in 90.5 % of C. difficileisolates. Two isolates from the ribotype 017 were toxin B positive only. Treatments with any of the following antimicrobials: clindamycin, erythromycin, ciprofloxacin and moxifloxacin (as well as many other antibiotics), could be a risk factor for CDI due to the high resistance of the strains in this study. About 90% of the strains from the most common ribotype 001/072 have MICs for clindamycin and erythromycin >256 μg/ml. CONCLUSION: All strains isolated are highly resistant to ciprofloxacin. All strains were susceptible to vancomycin (median MIC was 0.63 μg/ml) and metronidazole (median MIC was 0.084 μg/ml), so these two antimicrobials remain optimal treatmentoption for CDI

File(s)

Name

admin-oamjms-7-1896.pdf

Size

330.98 KB

Format

Adobe PDF

Checksum

(MD5):c42be73168b84b5f36bbd5b7671c5aac